Pliaglis

— THERAPEUTIC CATEGORIES —
  • Topical pain relief

Pliaglis Generic Name & Formulations

General Description

Lidocaine 7%, tetracaine 7%; emulsion cream.

Pharmacological Class

Topical anesthetic (amide-type + ester-type).

How Supplied

Cream—30g

Manufacturer

Generic Availability

NO

Pliaglis Indications

Indications

Local analgesia for superficial dermatological procedures (eg, dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, laser-assisted tattoo removal).

Pliaglis Dosage and Administration

Adult

Do not exceed recommended dose or duration. Apply to intact skin prior to procedure; spread evenly and thinly across treatment area using a metal spatula or tongue depressor. Dermal filler inj or facial laser ablation: apply for 20–30mins. Laser-assisted tattoo removal: apply for 60mins. Amount (length) to apply: see full labeling.

Children

Not established.

Pliaglis Contraindications

Contraindications

PABA hypersensitivity.

Pliaglis Boxed Warnings

Not Applicable

Pliaglis Warnings/Precautions

Warnings/Precautions

Risk of methemoglobinemia (esp. in G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants <6 months of age, concurrent exposure to oxidizing agents or metabolites); monitor. Avoid overexposure. Severe hepatic disease. Pseudocholinesterase deficiency. Risks of secondary exposure to children and pets; may be toxic. Avoid contact with eyes, mucous membranes, or areas with a compromised skin barrier (eg, broken or inflamed). Acutely ill. Debilitated. Elderly. Pregnancy. Nursing mothers.

Pliaglis Pharmacokinetics

See Literature

Pliaglis Interactions

Interactions

Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, others. Toxicity may be potentiated by Class I antiarrhythmics (eg, tocainide, mexiletine); caution. Additive effects with other products containing local anesthetics; consider the amount absorbed from all formulations.

Pliaglis Adverse Reactions

Adverse Reactions

Localized reactions (eg, erythema, skin discoloration, edema), allergic reactions (eg, urticaria, angioedema, bronchospasm, shock).

Pliaglis Clinical Trials

See Literature

Pliaglis Note

Not Applicable

Pliaglis Patient Counseling

See Literature

Images